Gelder Mark S. MD 4
4 · AP PHARMA INC /DE/ · Filed May 3, 2013
Insider Transaction Report
Form 4
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2013-05-01+2,000,000→ 2,000,000 totalExercise: $0.36Exp: 2023-05-01→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]Grant vests monthly over a 4 year period and will fully vest on May 1, 2017.